Scientific Information for Healthcare Professionals

I'd like to share with you a new communication that we sent out recently to more than 45,000 interventional and clinical cardiologists, vascular and cardiac surgeons, and other medical industry practitioners and customers.

As part of my role at Abbott Vascular of providing clinical leadership to guide decisions on internal pipeline technologies, clinical trials, new technology acquisitions and medical education, we created a new e-newsletter. The CMO Newsletter is aimed at providing updates in coronary, endovascular and structural heart technologies. Through this regular e-communication, our goal is to bring relevant new technology concepts and preclinical and clinical research data to readers, and to communicate my perspective as a clinician working in industry.

I hope you find these e-newsletters useful, and that they provide further insight into our exciting and rewarding business as a provider of next-generation products and technologies to our customers for the benefit of their patients.

Please note that these e-newsletters are for your educational purposes only and may not be reproduced, distributed or excerpted.

To access the latest newsletter, please click here.

Regards,
Chuck Simonton, M.D.
Chief Medical Officer and
Divisional Vice President, Medical Science Group
Abbott Vascular